Opportunity Information: Apply for CDC RFA GH21 2102
The Centers for Disease Control and Prevention (CDC), under the U.S. Department of Health and Human Services, offered a cooperative agreement funding opportunity titled "Capacity Building for Global, Regional, and National Immunization Programs" (Funding Opportunity Number: CDC RFA GH21-2102; CFDA 93.318). The grant is aimed at boosting the real-world capacity and performance of immunization programs in priority countries so they can meet major vaccine-preventable disease goals, including polio eradication and measles and rubella elimination. The larger public health intent is to reduce illness and deaths linked to vaccine-preventable diseases, while also strengthening preparedness for emerging threats like COVID-19 and supporting the groundwork needed for coronavirus vaccine introduction.
At its core, the opportunity focuses on building stronger systems that can prevent, detect, and respond to vaccine-preventable diseases. That includes improving immunization service delivery (so vaccines reliably reach people who need them), strengthening comprehensive vaccine-preventable disease surveillance (so health authorities can find cases quickly and track trends), and reinforcing the operational capacity required to prepare for, detect, and respond to outbreaks. The emphasis is not only on routine immunization performance, but also on the ability to surge during outbreaks and to close gaps that allow diseases to spread.
A key part of the work is targeted action to reach populations that are un-immunized or under-immunized, especially those considered high-risk. The recipient is expected to design and carry out strategies that improve access and raise vaccination coverage where it is weakest, which is often where outbreaks take hold. This means the award is not just about technical planning at the national level; it is also about practical, on-the-ground approaches to reaching missed communities and improving equity in immunization coverage.
The NOFO also puts weight on sustainability and smarter decision-making within national immunization programs. One of the mechanisms highlighted is support for evidence-based policy processes through National Immunization Technical Advisory Groups (NITAGs), which help countries evaluate scientific evidence and make informed decisions about immunization schedules and strategies. In addition, the recipient is expected to advance program evaluation and use findings to drive innovation, with the goal of increasing the overall impact of immunization investments over time rather than relying on short-term gains.
A distinct operational responsibility included in this opportunity is management and coordination of Pakistan's National Stop Transmission of Polio (NSTOP) program, along with support to countries experiencing polio outbreaks or at high risk of outbreaks. This signals a strong polio focus within the broader immunization strengthening agenda, tying global eradication priorities to the capacity-building work supported by the grant.
From an administrative standpoint, this was a discretionary funding opportunity using a cooperative agreement mechanism, meaning CDC would typically expect substantial involvement and collaboration during implementation compared to a standard grant. Eligibility was listed as unrestricted (open to any type of entity, subject to any additional eligibility clarifications in the full announcement). The opportunity anticipated a single award, with an award ceiling of $13,000,000. The NOFO was created on February 19, 2021, with an original application closing date of April 20, 2021, and electronic submissions due by 11:59 pm Eastern Time on the deadline date. Overall, the grant opportunity is designed to strengthen immunization systems in priority countries in a way that supports eradication and elimination targets, improves outbreak detection and response, reaches underserved populations, and reinforces the systems needed to address COVID-19 and future global health threats aligned with CDC goals.Apply for CDC RFA GH21 2102
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Capacity Building for Global, Regional, and National Immunization Programs" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.318.
- This funding opportunity was created on Feb 19, 2021.
- Applicants must submit their applications by Apr 20, 2021 Electronically submitted applications must be submitted no later than 1159 pm ET on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $13,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the name of this CDC funding opportunity?
The cooperative agreement funding opportunity is titled "Capacity Building for Global, Regional, and National Immunization Programs".
Who offered this grant opportunity?
This opportunity was offered by the Centers for Disease Control and Prevention (CDC) under the U.S. Department of Health and Human Services (HHS).
What is the Funding Opportunity Number (FONO) for this announcement?
The Funding Opportunity Number is CDC RFA GH21-2102.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.318.
What type of funding mechanism is being used?
This was a cooperative agreement, which typically means CDC expects substantial involvement and collaboration during implementation compared to a standard grant.
Is this considered discretionary funding?
Yes. The announcement describes this as a discretionary funding opportunity.
What is the main purpose of the grant?
The main purpose is to boost the real-world capacity and performance of immunization programs in priority countries so they can meet major vaccine-preventable disease goals, including polio eradication and measles and rubella elimination.
What public health outcomes is the grant trying to achieve?
The broader intent is to reduce illness and deaths linked to vaccine-preventable diseases, while also strengthening preparedness for emerging threats such as COVID-19 and supporting groundwork for coronavirus vaccine introduction.
What kinds of program capacities is the grant intended to strengthen?
The opportunity focuses on building systems that can prevent, detect, and respond to vaccine-preventable diseases. This includes:
- Improving immunization service delivery so vaccines reliably reach people who need them
- Strengthening comprehensive vaccine-preventable disease surveillance to find cases quickly and track trends
- Reinforcing operational capacity to prepare for, detect, and respond to outbreaks
Does the grant focus only on routine immunization?
No. While routine immunization performance is a key emphasis, the opportunity also stresses the ability to surge during outbreaks and to close gaps that allow vaccine-preventable diseases to spread.
Is reaching under-immunized or un-immunized populations part of the work?
Yes. A central component is targeted action to reach un-immunized or under-immunized populations, especially those considered high-risk. The recipient is expected to design and carry out strategies that improve access and increase coverage where it is weakest.
Is this opportunity mainly focused on national-level planning?
No. The description highlights that the award is not only about national-level technical planning. It also includes practical, on-the-ground approaches to reaching missed communities and improving equity in immunization coverage.
How does the opportunity address sustainability and better decision-making?
The NOFO emphasizes sustainability and improving decision-making within national immunization programs, including support for evidence-based policy processes through National Immunization Technical Advisory Groups (NITAGs).
What role do NITAGs play in this funding opportunity?
NITAGs are highlighted as a mechanism to help countries evaluate scientific evidence and make informed decisions about immunization schedules and strategies.
Is program evaluation included in the expectations for the recipient?
Yes. The recipient is expected to advance program evaluation and use findings to drive innovation, with the goal of increasing the impact of immunization investments over time rather than relying on short-term gains.
Is there a specific polio-related operational responsibility in this opportunity?
Yes. A distinct operational responsibility is the management and coordination of Pakistan's National Stop Transmission of Polio (NSTOP) program, along with support to countries experiencing polio outbreaks or at high risk of outbreaks.
Does the opportunity include support for countries beyond Pakistan?
Yes. In addition to Pakistan's NSTOP coordination, the opportunity includes supporting countries experiencing polio outbreaks or those at high risk of outbreaks.
How many awards were anticipated?
The opportunity anticipated a single award.
What was the award ceiling?
The award ceiling was $13,000,000.
Who was eligible to apply?
Eligibility was listed as unrestricted, meaning it was open to any type of entity, subject to any additional eligibility clarifications in the full announcement.
When was the NOFO created?
The NOFO was created on February 19, 2021.
What was the original application closing date?
The original application closing date was April 20, 2021.
What time were electronic submissions due on the deadline date?
Electronic submissions were due by 11:59 pm Eastern Time on the deadline date.
How does this opportunity relate to COVID-19?
The opportunity is intended to strengthen preparedness for emerging threats like COVID-19 and to support the groundwork needed for coronavirus vaccine introduction as part of stronger immunization systems.
What diseases or goals are specifically mentioned in the grant description?
The description specifically mentions major vaccine-preventable disease goals including polio eradication and measles and rubella elimination, alongside broader vaccine-preventable disease prevention, detection, and response.
What is the overall theme of the funded work?
The overall theme is strengthening immunization systems in priority countries to support eradication and elimination targets, improve outbreak detection and response, reach underserved populations, improve equity in vaccination coverage, and reinforce readiness for COVID-19 and future global health threats aligned with CDC goals.
Browse more opportunities from the same category: Health
Next opportunity: Managing the Mission Ukraine American Spaces Network to Support U.S. Engagement with Ukrainians
Previous opportunity: Market Development Cooperator Program 2021
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH21 2102
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH21 2102) also looked into and applied for these:
| Funding Opportunity |
|---|
| Capacity Building for National Immunization Programs in the Eastern Mediterranean Region Apply for CDC RFA GH21 2105 Funding Number: CDC RFA GH21 2105 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Telehealth Centers of Excellence Apply for HRSA 21 030 Funding Number: HRSA 21 030 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $3,250,000 |
| Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required) Apply for RFA HL 22 008 Funding Number: RFA HL 22 008 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enhancing the National Government's Coordination of the National HIV Program to Ensure Sustainability of Quality and Comprehensive HIV Services in Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2118 Funding Number: CDC RFA GH21 2118 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Sickle Cell Disease Newborn Screening Follow-up Program Apply for HRSA 21 036 Funding Number: HRSA 21 036 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $184,000 |
| Sickle Cell Disease Treatment Demonstration Program Apply for HRSA 21 032 Funding Number: HRSA 21 032 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving HIV/TB Policy Implementation in the KwaZulu Natal (KZN) Province in South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2133 Funding Number: CDC RFA GH21 2133 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening Public Health Responses and Accelerating HIV/AIDS Program for the Sustainable Provision of Comprehensive HIV/AIDS Services in Oromia Regional State of the Federal Democratic Republic of Ethiopia under PEPFAR Apply for CDC RFA GH21 2109 Funding Number: CDC RFA GH21 2109 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| ACL National Chronic Disease Self-Management Education Resource Center Apply for HHS 2021 ACL AOA CSSG 0020 Funding Number: HHS 2021 ACL AOA CSSG 0020 Agency: Department of Health and Human Services, Administration for Community Living Category: Health Funding Amount: $2,000,000 |
| NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) Apply for RFA DE 22 001 Funding Number: RFA DE 22 001 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $650,000 |
| NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 21 019 Funding Number: RFA RM 21 019 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $840,000 |
| Childhood Lead Poisoning Prevention and Surveillance of Blood Lead Levels in Children Apply for CDC RFA EH21 2102 Funding Number: CDC RFA EH21 2102 Agency: Department of Health and Human Services, Centers for Disease Control - NCEH Category: Health Funding Amount: $850,000 |
| Capacity Building for Sustainable HIV Services Apply for HRSA 21 064 Funding Number: HRSA 21 064 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Collecting Violent Death Information Using the National Violent Death Reporting System (NVDRS) Apply for CDC RFA CE21 2105 Funding Number: CDC RFA CE21 2105 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $942,085 |
| Medication Assisted Treatment - Prescription Drug and Opioid Addiction Apply for TI 21 006 Funding Number: TI 21 006 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $1,000,000 |
| Health Information Systems Strengthening for Improved Public Health Care and Program Management in Haiti under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2113 Funding Number: CDC RFA GH21 2113 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strategic Prevention Framework for Prescription Drugs Apply for SP 21 001 Funding Number: SP 21 001 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $384,000 |
| Development of a COVID-19 Monitoring System for U.S. Correctional and Detention Facilities Apply for CDC RFA PS21 2107 Funding Number: CDC RFA PS21 2107 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Community Action for HIV Control Activity Apply for 72012121RFA00001 Funding Number: 72012121RFA00001 Agency: Agency for International Development, Ukraine USAID-Kiev Category: Health Funding Amount: $19,500,000 |
| Strengthening HIV/AIDS-related Strategic Information, Laboratory Support, and Technical Assistance Services in Angola under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2148 Funding Number: CDC RFA GH21 2148 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH21 2102", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.